G1 THERAPEUTICS INC. - COMMON STOCK
4.0350
24-April-24 13:15:35
15 minutes delayed
Stocks
-0.1550
-3.70%
Today's range
4.0200 - 4.2350
ISIN
N/A
Source
NASDAQ
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2023 15:15:21 By Nasdaq GlobeNewswire
-
G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights
02 Aug 2023 05:30:27 By Nasdaq GlobeNewswire
-
G1 Therapeutics to Participate in Two August Investor Conferences
31 Jul 2023 13:30:27 By Nasdaq GlobeNewswire
-
31 Jul 2023 07:30:40 By Nasdaq GlobeNewswire
-
26 Jul 2023 08:00:31 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Jul 2023 15:15:03 By Nasdaq GlobeNewswire
-
04 Jun 2023 06:13:44 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Jun 2023 15:40:59 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Appointment of Monica Thomas as General Counsel
22 May 2023 15:45:22 By Nasdaq GlobeNewswire
-
16 May 2023 06:30:11 By Nasdaq GlobeNewswire
-
10 May 2023 06:31:04 By Nasdaq GlobeNewswire
-
G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights
03 May 2023 05:30:55 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 May 2023 16:00:50 By Nasdaq GlobeNewswire
-
26 Apr 2023 11:45:27 By Nasdaq GlobeNewswire
-
G1 Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 11:30:49 By Nasdaq GlobeNewswire
-
01 Mar 2023 05:30:27 By Nasdaq GlobeNewswire
-
G1 Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
28 Feb 2023 13:10:49 By Nasdaq GlobeNewswire
-
22 Feb 2023 09:00:17 By Nasdaq GlobeNewswire
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2023 15:46:01 By Nasdaq GlobeNewswire